NCT06717165

Brief Summary

This study aims to evaluate the feasibility and clinical outcome of the Exposure-based Cognitive-Behavioral Therapy (CBT) concurrent with Transcranial Alternating Current Stimulation (tACS) using individualized stimulation frequency in treating obsessive-compulsive disorder (OCD) patients, and explores the potential neural mechanisms of treatment effect by magnetic resonance imaging (MRI) and electroencephalography (EEG).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Apr 2024Dec 2027

Study Start

First participant enrolled

April 15, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

3.5 years

First QC Date

December 1, 2024

Last Update Submit

July 29, 2025

Conditions

Keywords

cognitive-behavioral therapyexposure and response preventiontranscranial alternating current stimulation

Outcome Measures

Primary Outcomes (1)

  • To explore the differences in treatment efficacy between active and sham transcranial alternating current stimulation (tACS) concurrent with exposure and response prevention (ERP)(tACS+ERP) in patients with obsessive-compulsive disorder (OCD).

    The primary outcome measure of this study is the change in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores from baseline at the completion of the 8th tACS + ERP treatment. Yale-Brown Obsessive Compulsive Scale (Y-BOCS):The total score of the scale ranges from 0 to 40, with higher scores indicating more severe symptoms.

    baseline, 2weeks, 4weeks,8 weeks (baseline, after Session 2, 5, 10)

Study Arms (2)

active tACS+exposure based CBT

ACTIVE COMPARATOR

The exposure and response prevention (ERP) treatment concurrently with an anode transcranial alternating current stimulation over the mPFC will be applied 8 times (tACS+ERP, 8 sessions) in the whole treatment.

Combination Product: ERP combined with high-definition active tACS

sham tACS +exposure based CBT

SHAM COMPARATOR

the exposure and response prevention (ERP) treatment concurrently with an sham transcranial alternating current stimulation over the mPFC will be applied 8 times (sham tACS+ERP, 8 sessions) in the whole treatment.

Combination Product: ERP combined with sham tACS

Interventions

The active tACS +ERP referred to a period of tACS applied in the first 20 minutes of the ERP treatment (the tACS device was activated when ERP began and deactivated automatically while ERP continued). The total treatment phase lasted eight weeks and included ten sessions with experienced psychotherapists following a specific manual for the tACS+ERP treatment. Based on the EEG parameters, individualized modeling was conducted to determine specific stimulation parameter schemes (stimulation frequency). Anode electrode will be localized in front of the mPFC on the Fz point according to the EEG international reference. Four cathode electrodes will be placed around (i.e. AFz, Fcz, F1, F2).

active tACS+exposure based CBT
ERP combined with sham tACSCOMBINATION_PRODUCT

Patients will get the same CBT setting as the active tACS group and they were applied the sham tACS cocurrently with ERP. The sham tACS device is the same as the active comparator's except that the sham tACS will only deliver a current stimulation for the first and last 15 seconds in order to produce somatic sensation in patients similar to that induced by the active tACS.

sham tACS +exposure based CBT

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may not qualify if:

  • years old
  • With at least 9 years of education
  • Y-BOCS score ≥16
  • Medication-free or had received stable medication for at least 8 weeks before entering the study and continued the same medication throughout the study
  • History of serious medical, neurological illness or other psychotic disorders other than OCD
  • OCD symptoms are severe, preventing the patient from completing the required assessment and examination
  • Serious suicide risk
  • Women who are pregnant or planning to become pregnant
  • Currently taking antiepileptic medication
  • Clinically significant physical illnesses or laboratory test abnormalities that have clinical significance
  • Previous completion of a full course of CBT/ERP treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Zhen Wang, PhD, MD

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhen Wang, PhD, MD

CONTACT

Zhen Wang, PhD, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-president

Study Record Dates

First Submitted

December 1, 2024

First Posted

December 4, 2024

Study Start

April 15, 2024

Primary Completion (Estimated)

October 30, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

August 1, 2025

Record last verified: 2025-07

Locations